{"id":816324,"date":"2025-02-21T13:46:16","date_gmt":"2025-02-21T18:46:16","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/astrazeneca-plc-securities-fraud-class-action-lawsuit-pending-contact-levi-korsinsky-before-february-21-2025-to-discuss-your-rights-azn-2\/"},"modified":"2025-02-21T13:46:16","modified_gmt":"2025-02-21T18:46:16","slug":"astrazeneca-plc-securities-fraud-class-action-lawsuit-pending-contact-levi-korsinsky-before-february-21-2025-to-discuss-your-rights-azn-2","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/astrazeneca-plc-securities-fraud-class-action-lawsuit-pending-contact-levi-korsinsky-before-february-21-2025-to-discuss-your-rights-azn-2\/","title":{"rendered":"AstraZeneca PLC Securities Fraud Class Action Lawsuit Pending: Contact Levi &amp; Korsinsky Before February 21, 2025 to Discuss Your Rights \u2013 AZN"},"content":{"rendered":"<div class=\"mw_release\">\n<p>NEW YORK, Feb.  21, 2025  (GLOBE NEWSWIRE) &#8212; Levi &amp; Korsinsky, LLP notifies investors in <strong>AstraZeneca PLC<\/strong> (&#8220;AstraZeneca&#8221; or the &#8220;Company&#8221;) (NASDAQ: AZN) of a class action securities lawsuit.<\/p>\n<p>\n        <strong>CLASS DEFINITION: <\/strong>The lawsuit seeks to recover losses on behalf of AstraZeneca investors who were adversely affected by alleged securities fraud between February 23, 2022 and December 17, 2024. Follow the link below to get more information and be contacted by a member of our team:<\/p>\n<p align=\"center\">\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=9AvpKfxdxv6dBJE79D2V98kaIWP8mpUsstP15a1xKYLh2fPSQoaem-1ABZX7oF61ZiOc-GS6LFvkl06tJi5b4V-uU4y_k7h7vjT6wq0JWTkJ76RNGTv_e8Z4r0l0YYymDJ3CrF6dtjhqStRr-cnnnKmGeg0koWenYp9VExRXwSodOxJgQk_zkkv3q7jT50g_Yjewrg3s5EayvDK5m9rkulsjYYVZOu-vchJITwqIGuj1M-q5XafD-I-Q-ix2TEt9\" rel=\"nofollow\" target=\"_blank\">https:\/\/zlk.com\/pslra-1\/astrazeneca-plc-lawsuit-submission-form?prid=130889&amp;wire=3<\/a>\n      <\/p>\n<p>\n        <strong>AZN<\/strong> investors may also contact Joseph E. Levi, Esq. via email at\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=3YEOisxLSA2quQxfag1RL0dpFUs-WcNJDsTL3nTNZhV5xsFz6XPeyrj_5wrK5vGMA2ilwfJyM7JPfQ-DjcpmtbbPCTcto7PMIC3XYut_aWQ=\" rel=\"nofollow\" target=\"_blank\">jlevi@levikorsinsky.com<\/a>\u00a0or by telephone at (212) 363-7500.<\/p>\n<p>\n        <strong>CASE DETAILS: <\/strong>The filed complaint alleges that defendants made false statements and\/or concealed that: (1) AstraZeneca engaged in insurance fraud in China; (2) as a result, AstraZeneca faced heightened legal exposure in China, which eventually resulted in the AstraZeneca China President being detained by Chinese law enforcement authorities; (3) as a result, AstraZeneca understated its legal risks; (4) the foregoing, once revealed, could materially harm AstraZeneca\u2019s business activities in China; and (5) as a result, defendants\u2019 statements about its business, operations, and prospects, were materially false and misleading and\/or lacked a reasonable basis at all relevant times.<\/p>\n<p>\n        <strong>WHAT&#8217;S NEXT? <\/strong>If you suffered a loss in AstraZeneca during the relevant time frame, you have until <strong>February 21, 2025<\/strong>\u00a0to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn&#8217;t require that you serve as a lead plaintiff.<\/p>\n<p>\n        <strong>NO COST TO YOU: <\/strong>If you are a class member, you may be entitled to compensation without payment of any out-of-pocket costs or fees. <strong>There is no cost or obligation to participate.<\/strong><\/p>\n<p>\n        <strong>WHY LEVI &amp; KORSINSKY: <\/strong>Over the past 20 years, the team at Levi &amp; Korsinsky has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. Our firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi &amp; Korsinsky has ranked in ISS Securities Class Action Services\u2019 Top 50 Report as one of the top securities litigation firms in the United States.<\/p>\n<p>\n        <strong>CONTACT:<\/strong><br \/>\n        <br \/>Levi &amp; Korsinsky, LLP <br \/>Joseph E. Levi, Esq.<br \/>Ed Korsinsky, Esq.<br \/>33 Whitehall Street, 17th Floor<br \/>New York, NY 10004<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=3YEOisxLSA2quQxfag1RL0dpFUs-WcNJDsTL3nTNZhWvQ8QA09frNW9ex6RbLFhq8j9-dQzH8aZkNx6hEEZx7govA0Uv8takya2pprc52n8=\" rel=\"nofollow\" target=\"_blank\">jlevi@levikorsinsky.com<\/a><br \/>Tel: (212) 363-7500<br \/>Fax: (212) 363-7171<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=qgzHdPAX4xijyplDHGbvu802kjVFqLldUBuKQhgz1aZ0wFdobcV6nPrxvSAMdFf1vUVWn3hXdjLlZIl7g2y0dQ==\" rel=\"nofollow\" target=\"_blank\">www.zlk.com<\/a><\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM2MjA3MyM2NzYxMzYxIzIwMjA0MjY=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/MWM0MzRiODEtNmVkMC00YmM0LWFhM2ItY2I3OTg4OWJlMzMxLTEwMzIyOTM=\/tiny\/Levi-Korsinsky-LLP.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>NEW YORK, Feb. 21, 2025 (GLOBE NEWSWIRE) &#8212; Levi &amp; Korsinsky, LLP notifies investors in AstraZeneca PLC (&#8220;AstraZeneca&#8221; or the &#8220;Company&#8221;) (NASDAQ: AZN) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of AstraZeneca investors who were adversely affected by alleged securities fraud between February 23, 2022 and December 17, 2024. Follow the link below to get more information and be contacted by a member of our team: https:\/\/zlk.com\/pslra-1\/astrazeneca-plc-lawsuit-submission-form?prid=130889&amp;wire=3 AZN investors may also contact Joseph E. Levi, Esq. via email at\u00a0jlevi@levikorsinsky.com\u00a0or by telephone at (212) 363-7500. CASE DETAILS: The filed complaint alleges that defendants made false statements and\/or concealed that: (1) AstraZeneca engaged in insurance fraud in China; (2) as a result, AstraZeneca &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/astrazeneca-plc-securities-fraud-class-action-lawsuit-pending-contact-levi-korsinsky-before-february-21-2025-to-discuss-your-rights-azn-2\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;AstraZeneca PLC Securities Fraud Class Action Lawsuit Pending: Contact Levi &amp; Korsinsky Before February 21, 2025 to Discuss Your Rights \u2013 AZN&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-816324","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>AstraZeneca PLC Securities Fraud Class Action Lawsuit Pending: Contact Levi &amp; Korsinsky Before February 21, 2025 to Discuss Your Rights \u2013 AZN - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/astrazeneca-plc-securities-fraud-class-action-lawsuit-pending-contact-levi-korsinsky-before-february-21-2025-to-discuss-your-rights-azn-2\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"AstraZeneca PLC Securities Fraud Class Action Lawsuit Pending: Contact Levi &amp; Korsinsky Before February 21, 2025 to Discuss Your Rights \u2013 AZN - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"NEW YORK, Feb. 21, 2025 (GLOBE NEWSWIRE) &#8212; Levi &amp; Korsinsky, LLP notifies investors in AstraZeneca PLC (&#8220;AstraZeneca&#8221; or the &#8220;Company&#8221;) (NASDAQ: AZN) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of AstraZeneca investors who were adversely affected by alleged securities fraud between February 23, 2022 and December 17, 2024. Follow the link below to get more information and be contacted by a member of our team: https:\/\/zlk.com\/pslra-1\/astrazeneca-plc-lawsuit-submission-form?prid=130889&amp;wire=3 AZN investors may also contact Joseph E. Levi, Esq. via email at\u00a0jlevi@levikorsinsky.com\u00a0or by telephone at (212) 363-7500. CASE DETAILS: The filed complaint alleges that defendants made false statements and\/or concealed that: (1) AstraZeneca engaged in insurance fraud in China; (2) as a result, AstraZeneca &hellip; Continue reading &quot;AstraZeneca PLC Securities Fraud Class Action Lawsuit Pending: Contact Levi &amp; Korsinsky Before February 21, 2025 to Discuss Your Rights \u2013 AZN&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/astrazeneca-plc-securities-fraud-class-action-lawsuit-pending-contact-levi-korsinsky-before-february-21-2025-to-discuss-your-rights-azn-2\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-02-21T18:46:16+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM2MjA3MyM2NzYxMzYxIzIwMjA0MjY=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/astrazeneca-plc-securities-fraud-class-action-lawsuit-pending-contact-levi-korsinsky-before-february-21-2025-to-discuss-your-rights-azn-2\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/astrazeneca-plc-securities-fraud-class-action-lawsuit-pending-contact-levi-korsinsky-before-february-21-2025-to-discuss-your-rights-azn-2\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"AstraZeneca PLC Securities Fraud Class Action Lawsuit Pending: Contact Levi &amp; Korsinsky Before February 21, 2025 to Discuss Your Rights \u2013 AZN\",\"datePublished\":\"2025-02-21T18:46:16+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/astrazeneca-plc-securities-fraud-class-action-lawsuit-pending-contact-levi-korsinsky-before-february-21-2025-to-discuss-your-rights-azn-2\\\/\"},\"wordCount\":400,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/astrazeneca-plc-securities-fraud-class-action-lawsuit-pending-contact-levi-korsinsky-before-february-21-2025-to-discuss-your-rights-azn-2\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM2MjA3MyM2NzYxMzYxIzIwMjA0MjY=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/astrazeneca-plc-securities-fraud-class-action-lawsuit-pending-contact-levi-korsinsky-before-february-21-2025-to-discuss-your-rights-azn-2\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/astrazeneca-plc-securities-fraud-class-action-lawsuit-pending-contact-levi-korsinsky-before-february-21-2025-to-discuss-your-rights-azn-2\\\/\",\"name\":\"AstraZeneca PLC Securities Fraud Class Action Lawsuit Pending: Contact Levi &amp; Korsinsky Before February 21, 2025 to Discuss Your Rights \u2013 AZN - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/astrazeneca-plc-securities-fraud-class-action-lawsuit-pending-contact-levi-korsinsky-before-february-21-2025-to-discuss-your-rights-azn-2\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/astrazeneca-plc-securities-fraud-class-action-lawsuit-pending-contact-levi-korsinsky-before-february-21-2025-to-discuss-your-rights-azn-2\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM2MjA3MyM2NzYxMzYxIzIwMjA0MjY=\",\"datePublished\":\"2025-02-21T18:46:16+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/astrazeneca-plc-securities-fraud-class-action-lawsuit-pending-contact-levi-korsinsky-before-february-21-2025-to-discuss-your-rights-azn-2\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/astrazeneca-plc-securities-fraud-class-action-lawsuit-pending-contact-levi-korsinsky-before-february-21-2025-to-discuss-your-rights-azn-2\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/astrazeneca-plc-securities-fraud-class-action-lawsuit-pending-contact-levi-korsinsky-before-february-21-2025-to-discuss-your-rights-azn-2\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM2MjA3MyM2NzYxMzYxIzIwMjA0MjY=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM2MjA3MyM2NzYxMzYxIzIwMjA0MjY=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/astrazeneca-plc-securities-fraud-class-action-lawsuit-pending-contact-levi-korsinsky-before-february-21-2025-to-discuss-your-rights-azn-2\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"AstraZeneca PLC Securities Fraud Class Action Lawsuit Pending: Contact Levi &amp; Korsinsky Before February 21, 2025 to Discuss Your Rights \u2013 AZN\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"AstraZeneca PLC Securities Fraud Class Action Lawsuit Pending: Contact Levi &amp; Korsinsky Before February 21, 2025 to Discuss Your Rights \u2013 AZN - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/astrazeneca-plc-securities-fraud-class-action-lawsuit-pending-contact-levi-korsinsky-before-february-21-2025-to-discuss-your-rights-azn-2\/","og_locale":"en_US","og_type":"article","og_title":"AstraZeneca PLC Securities Fraud Class Action Lawsuit Pending: Contact Levi &amp; Korsinsky Before February 21, 2025 to Discuss Your Rights \u2013 AZN - Market Newsdesk","og_description":"NEW YORK, Feb. 21, 2025 (GLOBE NEWSWIRE) &#8212; Levi &amp; Korsinsky, LLP notifies investors in AstraZeneca PLC (&#8220;AstraZeneca&#8221; or the &#8220;Company&#8221;) (NASDAQ: AZN) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of AstraZeneca investors who were adversely affected by alleged securities fraud between February 23, 2022 and December 17, 2024. Follow the link below to get more information and be contacted by a member of our team: https:\/\/zlk.com\/pslra-1\/astrazeneca-plc-lawsuit-submission-form?prid=130889&amp;wire=3 AZN investors may also contact Joseph E. Levi, Esq. via email at\u00a0jlevi@levikorsinsky.com\u00a0or by telephone at (212) 363-7500. CASE DETAILS: The filed complaint alleges that defendants made false statements and\/or concealed that: (1) AstraZeneca engaged in insurance fraud in China; (2) as a result, AstraZeneca &hellip; Continue reading \"AstraZeneca PLC Securities Fraud Class Action Lawsuit Pending: Contact Levi &amp; Korsinsky Before February 21, 2025 to Discuss Your Rights \u2013 AZN\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/astrazeneca-plc-securities-fraud-class-action-lawsuit-pending-contact-levi-korsinsky-before-february-21-2025-to-discuss-your-rights-azn-2\/","og_site_name":"Market Newsdesk","article_published_time":"2025-02-21T18:46:16+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM2MjA3MyM2NzYxMzYxIzIwMjA0MjY=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/astrazeneca-plc-securities-fraud-class-action-lawsuit-pending-contact-levi-korsinsky-before-february-21-2025-to-discuss-your-rights-azn-2\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/astrazeneca-plc-securities-fraud-class-action-lawsuit-pending-contact-levi-korsinsky-before-february-21-2025-to-discuss-your-rights-azn-2\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"AstraZeneca PLC Securities Fraud Class Action Lawsuit Pending: Contact Levi &amp; Korsinsky Before February 21, 2025 to Discuss Your Rights \u2013 AZN","datePublished":"2025-02-21T18:46:16+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/astrazeneca-plc-securities-fraud-class-action-lawsuit-pending-contact-levi-korsinsky-before-february-21-2025-to-discuss-your-rights-azn-2\/"},"wordCount":400,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/astrazeneca-plc-securities-fraud-class-action-lawsuit-pending-contact-levi-korsinsky-before-february-21-2025-to-discuss-your-rights-azn-2\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM2MjA3MyM2NzYxMzYxIzIwMjA0MjY=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/astrazeneca-plc-securities-fraud-class-action-lawsuit-pending-contact-levi-korsinsky-before-february-21-2025-to-discuss-your-rights-azn-2\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/astrazeneca-plc-securities-fraud-class-action-lawsuit-pending-contact-levi-korsinsky-before-february-21-2025-to-discuss-your-rights-azn-2\/","name":"AstraZeneca PLC Securities Fraud Class Action Lawsuit Pending: Contact Levi &amp; Korsinsky Before February 21, 2025 to Discuss Your Rights \u2013 AZN - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/astrazeneca-plc-securities-fraud-class-action-lawsuit-pending-contact-levi-korsinsky-before-february-21-2025-to-discuss-your-rights-azn-2\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/astrazeneca-plc-securities-fraud-class-action-lawsuit-pending-contact-levi-korsinsky-before-february-21-2025-to-discuss-your-rights-azn-2\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM2MjA3MyM2NzYxMzYxIzIwMjA0MjY=","datePublished":"2025-02-21T18:46:16+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/astrazeneca-plc-securities-fraud-class-action-lawsuit-pending-contact-levi-korsinsky-before-february-21-2025-to-discuss-your-rights-azn-2\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/astrazeneca-plc-securities-fraud-class-action-lawsuit-pending-contact-levi-korsinsky-before-february-21-2025-to-discuss-your-rights-azn-2\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/astrazeneca-plc-securities-fraud-class-action-lawsuit-pending-contact-levi-korsinsky-before-february-21-2025-to-discuss-your-rights-azn-2\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM2MjA3MyM2NzYxMzYxIzIwMjA0MjY=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM2MjA3MyM2NzYxMzYxIzIwMjA0MjY="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/astrazeneca-plc-securities-fraud-class-action-lawsuit-pending-contact-levi-korsinsky-before-february-21-2025-to-discuss-your-rights-azn-2\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"AstraZeneca PLC Securities Fraud Class Action Lawsuit Pending: Contact Levi &amp; Korsinsky Before February 21, 2025 to Discuss Your Rights \u2013 AZN"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/816324","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=816324"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/816324\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=816324"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=816324"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=816324"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}